New research published online in the Journal of Leukocyte Biology showed for the first time that mature monocytes (a specific type of white blood cell) express the CXCR7 receptor on their surface.

Researchers have discovered an unlikely relationship between CXCR7 -- a protein implicated in tumor growth and metastasis -- and adrenomedullin -- a hormone involved in cardiovascular health. Deleting ...

The oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 plus lomustine in patients with treatment-refractory malignant glioma: The first human dose study.

Circle Pharma, Inc. today announced that results from its collaborative work with Pfizer Inc. to develop a potent and orally bioavailable macrocycle modulator of the chemokine receptor, CXCR7, have ...

(MENAFN- Zex PR Wire) LONDON, UK, 15th January 2026, ZEX PR WIRE, Stelios Tzellos, Ph.D., is the co-author of multiple peer-reviewed research studies focused on gene regulation by the Epstein-Barr ...

HLA-G expression and miR-148a, miR-152 in colorectal adenocarcinoma. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.

Researchers from Ileadbms Co. Ltd. presented the discovery and preclinical characterization of IL-21120033, a new CXCR7 agonist being developed for the treatment of inflammatory bowel disease.

New research has shown for the first time that mature monocytes (a specific type of white blood cell) express the CXCR7 receptor on their surface. This receptor may be a therapeutic target for ...